TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
-2.75%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.85B
AUM Growth
+$2.85B
(-8.4%)
Cap. Flow
-$72.4M
Cap. Flow
% of AUM
-2.54%
Top 10 Holdings %
Top 10 Hldgs %
35.96%
Holding
185
New
14
Increased
26
Reduced
25
Closed
10
Top Buys
| 1 |
AstraZeneca
AZN
|
$13.5M |
| 2 |
Stryker
SYK
|
$11.3M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$9.35M |
| 4 |
SPDR S&P Biotech ETF
XBI
|
$8.6M |
| 5 |
Becton Dickinson
BDX
|
$8.15M |
Top Sells
| 1 |
Moderna
MRNA
|
$37.6M |
| 2 |
Thermo Fisher Scientific
TMO
|
$32.3M |
| 3 |
Merck
MRK
|
$17.4M |
| 4 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$16.4M |
| 5 |
Danaher
DHR
|
$15.3M |
Sector Composition
| 1 | Healthcare | 95.64% |
| 2 | Real Estate | 3.21% |
| 3 | Industrials | 0.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZGNX
176
DELISTED
Zogenix, Inc.
ZGNX
| – | – |
-88,977
| Closed | -$1.45M |
|
|
ARNA
177
DELISTED
Arena Pharmaceuticals Inc
ARNA
| – | – |
-175,976
| Closed | -$16.4M |
|
|
FMTX
178
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| – | – |
-53,186
| Closed | -$756K |
|
179
Theravance Biopharma
TBPH
$691M
| – | – |
-656,296
| Closed | -$7.25M |
|
180
Mettler-Toledo International
MTD
$26.1B
| – | – |
-6,650
| Closed | -$11.3M |
|
181
Kodiak Sciences
KOD
$453M
| – | – |
-8,530
| Closed | -$723K |
|
182
KalVista Pharmaceuticals
KALV
$713M
| – | – |
-31,594
| Closed | -$418K |
|
183
IDEAYA Biosciences
IDYA
$2.26B
| – | – |
-20,454
| Closed | -$484K |
|